Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 2Thrombophilia 1Rectal Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Stromal Tumors 1EGFR-Mutant Lung Cancer 1Deglutition Disorders 1Communication Disorders 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Pancreatic Ductal 1Carcinoma 1Brain Neoplasms 1Blood Coagulation Disorders 1Adenocarcinoma 1

Interventions

Temozolomide 94Radiotherapy 59Bevacizumab 59Radiosurgery 41Carboplatin 27Irinotecan 26Magnetic Resonance Spectroscopy 25Surgical Procedures, Operative 23Etoposide 22Carmustine 20Filgrastim 18Erlotinib Hydrochloride 17Cyclophosphamide 16Cisplatin 16Vincristine 15Lomustine 15Lapatinib 15Sorafenib 13Radiation 13Trastuzumab 12Nivolumab 12Imatinib Mesylate 12Thalidomide 11Surveys and Questionnaires 11Granulocyte Colony-Stimulating Factor 11Radiotherapy, Intensity-Modulated 10Aminolevulinic Acid 10temsirolimus 9Topotecan 9Thiotepa 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Brain Neoplasms × Lead × Clear all
NCT00599703 2009-07-08

Language Function in Patients With Brain Tumors

Memorial Sloan Kettering Cancer Center

Completed
7 enrolled
CNS

Brain Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡